These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 18414077)

  • 1. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C.
    Nylen ES; Marathe IC; Khan IA; Azevedo R; Hirsch KR
    Am J Med Sci; 2008 Apr; 335(4):329-30. PubMed ID: 18414077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?
    Tosone G; Borgia G; Gentile I; Cerini R; Conte MC; Orlando R; Piazza M
    Acta Diabetol; 2007 Sep; 44(3):167-9. PubMed ID: 17721757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
    Jensen DM; Krawitt EL; Keeffe EB; Hollinger FB; James SP; Mullen K; Everson GT; Hoefs JC; Fromm H; Black M; Foust RT; Pimstone NR; Heathcote EJ; Albert D
    Am J Gastroenterol; 1999 Dec; 94(12):3583-8. PubMed ID: 10606323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
    Lee WM; Reddy KR; Tong MJ; Black M; van Leeuwen DJ; Hollinger FB; Mullen KD; Pimstone N; Albert D; Gardner S
    Hepatology; 1998 Nov; 28(5):1411-5. PubMed ID: 9794929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
    Heathcote EJ; James S; Mullen KD; Hauser SC; Rosenblate H; Albert DG
    Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C.
    Recasens M; Aguilera E; Ampurdanés S; Sánchez Tapias JM; Simó O; Casamitjana R; Conget I
    Diabet Med; 2001 Sep; 18(9):764-7. PubMed ID: 11606177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.
    Borgia G; Reynaud L; Gentile I; Cerini R; Ciampi R; Dello Russo M; Piazza M
    J Interferon Cytokine Res; 2001 Jul; 21(7):469-70. PubMed ID: 11506739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ; Lee SD; Chan CY; Lu RH; Chang FY
    Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of severe diabetic keto-acidosis with shock after changing interferon-beta into interferon-alpha for chronic hepatitis C.
    Hayakawa M; Gando S; Morimoto Y; Kemmotsu O
    Intensive Care Med; 2000 Jul; 26(7):1008. PubMed ID: 10990121
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous mucinosis and skin necrosis complicates interferon alfacon-1 (consensus interferon) treatment of chronic hepatitis C.
    Siewert E; Weyers W; Dietrich CG; Geier A; Lammert F; Matern S
    Eur J Med Res; 2005 Feb; 10(2):63-7. PubMed ID: 15817424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C.
    Tahara H; Kojima A; Hirokawa T; Oyama T; Naganuma A; Maruta S; Okada K; Ban S; Yoshida K; Takagi H; Mori M
    Intern Med; 2007; 46(8):473-6. PubMed ID: 17443037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus during interferon therapy for chronic viral hepatitis.
    Mofredj A; Howaizi M; Grasset D; Licht H; Loison S; Devergie B; Demontis R; Cadranel JF
    Dig Dis Sci; 2002 Jul; 47(7):1649-54. PubMed ID: 12141831
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Augmentation of the immune response to islet cell antigens with development of diabetes mellitus caused by interferon-alpha therapy in chronic hepatitis C].
    Seifarth C; Benninger J; Böhm BO; Wiest-Ladenburger U; Hahn EG; Hensen J
    Z Gastroenterol; 1999 Mar; 37(3):235-9. PubMed ID: 10234796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.
    Brinovec V; Lesnicar G; Maticic M; Meglic-Volkar J; Poljak M; Seme K; Ferlan-Marolt V
    Hepatogastroenterology; 2002; 49(47):1320-5. PubMed ID: 12239935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.